IPOs This Week: 5/14/18

Biotech stocks came under pressure last week despite two FDA approvals coming through. The FDA approved SAGE Therapeutics Inc (NASDAQ:.....»»

Don't look now, but 2019 may be shaping up to continue an Initial Public Offering (IPO) market that had been dormant just a few short years ago. Want the latest recommendations from Zacks Inves.....»»

Lyft plans to launch the roadshow next week leading up to one of the largest and most highly anticipated IPOs in recent years. Here’s a look at what an IPO roadshow is and what investors can expect. read more.....»»

Last week was an event-filled one for the biotech space, with M&A, FDA decisions, clinical trial results and earnings all on offer. read more.....»»

Last week was an event-filled one for the biotech space, with M&A, FDA decisions, clinical trial results and&nb.....»»

U.S. IPO Week Ahead: No IPOs, But Plenty Of Potential Launches.....»»

It was an event-filled one for biotech stocks, with the release of a slew of earnings, presentations of clinical trial results an.....»»

The February l.....»»

U.S. IPO Week Ahead: 2 Growth IPOs Kick Off A More Active March.....»»

IPOs This Week.....»»

Six IPOs are on the calendar for the coming week including tech unicorns DocuSign and Ceridian HCM. The IPO market for the year to date has been well above last year's performance......»»

Eight IPOs on the coming week's calendar are seeking to raise more than $2.6 billion in capital......»»

U.S. IPO Week Ahead: A Pivotal Week With 8 IPOs.....»»

Eight deals are on the calenda.....»»

The two IPOs on this week's calendar include one tech unicorn and a biotech working on a treatment from Alzheimer disease......»»

Here's a few must-watch biotech catalysts this week. Conferences Panamerican League of Associations for Rheumatology Congress – April 7-11 at Hotel Hilton, Buenos Aires, Argentina. read more.....»»

After a week that saw 5 successful IPOs, we'll see another 8 firms taking their shots at entering the capital markets in the coming week. The 8 companies are seeking more than $700 million in public........»»

Aft.....»»

After eking out a modest gain in the week ended April 27, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) pulled back this week amid some not-so-encouraging earnings reports and negative regulatory decisions. read more.....»»

This Week"s IPOs: 5/7/18.....»»